Want to join the conversation?
For the full fiscal year 2015, $BDX reported profit of $695MM or $3.35 per share, and revenue of $10.28Bil. On a reported basis, $BDX expects full fiscal year 2016 revenue to increase 23-23.5% compared to 2015, and diluted EPS to be between $6.57 and $6.64.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?